Epigenetic control of tumor suppression

Stela S. Palii, Keith D Robertson

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Epigenetic silencing of tumor suppressor genes is a major contributor to neoplastic transformation and is an area of intense research. Identification of genes that undergo cancer-specific CpG island hypermethylation in combination with repressive histone tail modifications (deacetylation and methylation) and correlation of these data with tumor stage, progression, and long-term prognosis are becoming increasingly common. The efforts directed toward elucidating the mechanisms of neoplastic tumor suppression catalyzed the convergence of epigenetics, chromatin remodeling, and pharmacology of epigenome-altering drugs. This review discusses the key findings and current concepts concerning the epigenetic control of tumor suppression and analyzes the role of DNA hypermethylation in conjunction with histone deacetylation and methylation profiles of tumor suppressor genes as it relates to epigenetic loss of function in malignancy. Examples arguing for hierarchic control and interdependent regulation within the cellular tumor suppression networks are also presented. Finally, the necessity of a human epigenome database integrating the continually produced experimental information for use by both researchers and clinicians for prospective translational multidisciplinary studies of tumor suppressor networks is rationalized.

Original languageEnglish (US)
Pages (from-to)295-316
Number of pages22
JournalCritical Reviews in Eukaryotic Gene Expression
Volume17
Issue number4
StatePublished - 2007
Externally publishedYes

Fingerprint

Epigenomics
Neoplasms
Tumor Suppressor Genes
Methylation
Histone Code
CpG Islands
Chromatin Assembly and Disassembly
Neoplasm Genes
Histones
Tail
Research Personnel
Databases
Pharmacology
DNA
Research
Pharmaceutical Preparations

Keywords

  • Carcinogenesis
  • Deacetylation
  • DNMT1
  • Epigenome
  • Histone modification
  • Hypermethylation
  • Silencing

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology

Cite this

Epigenetic control of tumor suppression. / Palii, Stela S.; Robertson, Keith D.

In: Critical Reviews in Eukaryotic Gene Expression, Vol. 17, No. 4, 2007, p. 295-316.

Research output: Contribution to journalArticle

@article{53af269846cc4e5bbb2c44263d055491,
title = "Epigenetic control of tumor suppression",
abstract = "Epigenetic silencing of tumor suppressor genes is a major contributor to neoplastic transformation and is an area of intense research. Identification of genes that undergo cancer-specific CpG island hypermethylation in combination with repressive histone tail modifications (deacetylation and methylation) and correlation of these data with tumor stage, progression, and long-term prognosis are becoming increasingly common. The efforts directed toward elucidating the mechanisms of neoplastic tumor suppression catalyzed the convergence of epigenetics, chromatin remodeling, and pharmacology of epigenome-altering drugs. This review discusses the key findings and current concepts concerning the epigenetic control of tumor suppression and analyzes the role of DNA hypermethylation in conjunction with histone deacetylation and methylation profiles of tumor suppressor genes as it relates to epigenetic loss of function in malignancy. Examples arguing for hierarchic control and interdependent regulation within the cellular tumor suppression networks are also presented. Finally, the necessity of a human epigenome database integrating the continually produced experimental information for use by both researchers and clinicians for prospective translational multidisciplinary studies of tumor suppressor networks is rationalized.",
keywords = "Carcinogenesis, Deacetylation, DNMT1, Epigenome, Histone modification, Hypermethylation, Silencing",
author = "Palii, {Stela S.} and Robertson, {Keith D}",
year = "2007",
language = "English (US)",
volume = "17",
pages = "295--316",
journal = "Critical Reviews in Eukaryotic Gene Expression",
issn = "1045-4403",
publisher = "Begell House Inc.",
number = "4",

}

TY - JOUR

T1 - Epigenetic control of tumor suppression

AU - Palii, Stela S.

AU - Robertson, Keith D

PY - 2007

Y1 - 2007

N2 - Epigenetic silencing of tumor suppressor genes is a major contributor to neoplastic transformation and is an area of intense research. Identification of genes that undergo cancer-specific CpG island hypermethylation in combination with repressive histone tail modifications (deacetylation and methylation) and correlation of these data with tumor stage, progression, and long-term prognosis are becoming increasingly common. The efforts directed toward elucidating the mechanisms of neoplastic tumor suppression catalyzed the convergence of epigenetics, chromatin remodeling, and pharmacology of epigenome-altering drugs. This review discusses the key findings and current concepts concerning the epigenetic control of tumor suppression and analyzes the role of DNA hypermethylation in conjunction with histone deacetylation and methylation profiles of tumor suppressor genes as it relates to epigenetic loss of function in malignancy. Examples arguing for hierarchic control and interdependent regulation within the cellular tumor suppression networks are also presented. Finally, the necessity of a human epigenome database integrating the continually produced experimental information for use by both researchers and clinicians for prospective translational multidisciplinary studies of tumor suppressor networks is rationalized.

AB - Epigenetic silencing of tumor suppressor genes is a major contributor to neoplastic transformation and is an area of intense research. Identification of genes that undergo cancer-specific CpG island hypermethylation in combination with repressive histone tail modifications (deacetylation and methylation) and correlation of these data with tumor stage, progression, and long-term prognosis are becoming increasingly common. The efforts directed toward elucidating the mechanisms of neoplastic tumor suppression catalyzed the convergence of epigenetics, chromatin remodeling, and pharmacology of epigenome-altering drugs. This review discusses the key findings and current concepts concerning the epigenetic control of tumor suppression and analyzes the role of DNA hypermethylation in conjunction with histone deacetylation and methylation profiles of tumor suppressor genes as it relates to epigenetic loss of function in malignancy. Examples arguing for hierarchic control and interdependent regulation within the cellular tumor suppression networks are also presented. Finally, the necessity of a human epigenome database integrating the continually produced experimental information for use by both researchers and clinicians for prospective translational multidisciplinary studies of tumor suppressor networks is rationalized.

KW - Carcinogenesis

KW - Deacetylation

KW - DNMT1

KW - Epigenome

KW - Histone modification

KW - Hypermethylation

KW - Silencing

UR - http://www.scopus.com/inward/record.url?scp=34347380937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34347380937&partnerID=8YFLogxK

M3 - Article

C2 - 17725495

AN - SCOPUS:34347380937

VL - 17

SP - 295

EP - 316

JO - Critical Reviews in Eukaryotic Gene Expression

JF - Critical Reviews in Eukaryotic Gene Expression

SN - 1045-4403

IS - 4

ER -